Ryczaj Klaudia, Dumycz Karolina, Spiewak Radoslaw, Feleszko Wojciech
Department of Pediatric Pneumonology and Allergy Medical University of Warsaw Warsaw Poland.
Doctoral School Medical University of Warsaw Warsaw Poland.
Clin Transl Allergy. 2022 Jun 5;12(6):e12150. doi: 10.1002/clt2.12150. eCollection 2022 Jun.
Results of preventative emollient therapy on atopic dermatitis and food allergy trials are inconsistent. In addition to the ingredients considered beneficial, the moisturizers may contain potentially harmful haptens. This study aimed to assess the prevalence of haptens in moisturizers used in studies to prevent atopic dermatitis or food allergy and assess their correlations to the trial results.
A systematic search of studies investigating the role of emollient usage in preventing atopic dermatitis or food allergy in infants was performed from inception to December 2020. Haptens were identified based on the nine common patch test series (European, American, and Australian).
12 clinical trial studies were included in the review. In total, 16 different emollients were applied as an intervention. The vast majority (75%) of preparations contained at least one hapten from which several substances pose high allergic or irritant potential. Quantitative data synthesis of the findings regarding food allergy and atopic dermatitis prevention was not possible due to the significant heterogeneity of preparations used.
Careful selection of emollient should consider the absence of potentially harmful ingredients, particularly when used in youngest children. Chronic skin exposure to haptens promotes the development of allergic contact dermatitis and moreover, via deterioration of the skin barrier and subclinical inflammation, may facilitate epicutaneous sensitization and promote atopic dermatitis; however further research is needed to validate our suppositions.
预防性润肤疗法对特应性皮炎和食物过敏试验的结果并不一致。除了被认为有益的成分外,保湿剂可能含有潜在有害的半抗原。本研究旨在评估用于预防特应性皮炎或食物过敏的研究中使用的保湿剂中半抗原的患病率,并评估它们与试验结果的相关性。
对从开始到2020年12月期间调查润肤剂使用在预防婴儿特应性皮炎或食物过敏中的作用的研究进行系统检索。根据九个常见的斑贴试验系列(欧洲、美国和澳大利亚)来识别半抗原。
该综述纳入了12项临床试验研究。总共应用了16种不同的润肤剂作为干预措施。绝大多数(75%)的制剂含有至少一种半抗原,其中几种物质具有很高的过敏或刺激潜力。由于所用制剂存在显著异质性,因此无法对有关食物过敏和特应性皮炎预防的研究结果进行定量数据综合分析。
仔细选择润肤剂时应考虑避免含有潜在有害成分,尤其是在用于最小的儿童时。皮肤长期接触半抗原会促进过敏性接触性皮炎发展,此外,通过皮肤屏障的恶化和亚临床炎症,可能会促进经皮致敏并引发特应性皮炎;然而,需要进一步研究来验证我们的推测。